Interleukin-6 promoter polymorphism and cardiovascular risk factors: The Health 2000 Survey

Atherosclerosis

Volumn 207, Issue 2, 2009, Pages 466-470

  Riikola, Antti ^a   Sipilä, Kalle ^b   Kähönen, Mika ^a,b   Jula, Antti ^c   Nieminen, Markku S ^d   Moilanen, Leena ^e   Kesäniemi, Y Antero ^f   Lehtimäki, Terho ^a,b   Hulkkonen, Janne ^b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

^f UNIVERSITY OF OULU   (Finland)

Author keywords

Atherosclerosis; Cytokine; Genetics; Interleukin 6; Polymorphism

Indexed keywords

CHOLESTEROL; GLUCOSE; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALLELE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; FEMALE; FINLAND; GENETIC POLYMORPHISM; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SYSTOLIC BLOOD PRESSURE;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; CHOLESTEROL; CROSS-SECTIONAL STUDIES; FEMALE; FINLAND; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEALTH SURVEYS; HUMANS; INSULIN; INTERLEUKIN-6; LINEAR MODELS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS;

EID: 70450227447     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.06.004     Document Type: Article

References (40)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
2. Bennet A.M., Prince J.A., Fei G.Z., et al. Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction. Atherosclerosis 171 (2003) 359-367
3. Ridker P.M., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000) 1767-1772
4. Burzotta F., Iacoviello L., Di Castelnuovo A., et al. Relation of the -174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am J Cardiol 88 (2001) 1125-1128
5. Fishman D., Faulds G., Jeffery R., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102 (1998) 1369-1376
6. Hulkkonen J., Pertovaara M., Antonen J., Pasternack A., and Hurme M. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren's syndrome and correlate with the clinical manifestations of the disease. Rheumatology (Oxford) 40 (2001) 656-661
7. Huth C., Illig T., Herder C., et al. Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant -174G>C with circulating glucose levels, interleukin-6 levels, and body mass index. Ann Med (2008) 1-21
8. Sanderson S.C., Kumari M., Brunner E.J., et al. Association between IL6 gene variants -174G>C and -572G>C and serum IL-6 levels: interactions with social position in the Whitehall II cohort. Atherosclerosis 204 (2009) 459-464
9. Lalouschek W., Schillinger M., Hsieh K., et al. Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events. Clin Chem Lab Med 44 (2006) 918-923
10. Chiappelli M., Tampieri C., Tumini E., et al. Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. Int J Immunogenet 32 (2005) 349-353
11. Humphries S.E., Luong L.A., Ogg M.S., Hawe E., and Miller G.J. The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 22 (2001) 2243-2252
12. Bruunsgaard H., Christiansen L., Pedersen A.N., et al. The IL-6 -174G>C polymorphism is associated with cardiovascular diseases and mortality in 80-year-old humans. Exp Gerontol 39 (2004) 255-261
13. Hurme M., Lehtimäki T., Jylhä M., Karhunen P.J., and Hervonen A. Interleukin-6 -174G/C polymorphism and longevity: a follow-up study. Mech Ageing Dev 126 (2005) 417-418
14. Hulkkonen J., Lehtimäki T., Mononen N., et al. Polymorphism in the IL6 promoter region is associated with the risk factors and markers of subclinical atherosclerosis in men: the Cardiovascular Risk in Young Finns Study. Atherosclerosis 203 (2009) 454-458
15. Sie M.P., Sayed-Tabatabaei F.A., Oei H.H., et al. Interleukin 6 -174 g/c promoter polymorphism and risk of coronary heart disease: results from the Rotterdam study and a meta-analysis. Arterioscler Thromb Vasc Biol 26 (2006) 212-217
16. Juonala M., Viikari J.S., Kähönen M., et al. Geographic origin as a determinant of carotid artery intima-media thickness and brachial artery flow-mediated dilation: the Cardiovascular Risk in Young Finns Study. Arterioscler Thromb Vasc Biol 25 (2005) 392-398
17. Blacher J., Pannier B., Guerin A.P., et al. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 32 (1998) 570-574
18. Oliver J.J., and Webb D.J. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 23 (2003) 554-566
19. Raitakari O.T., Juonala M., Kähönen M., et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 290 (2003) 2277-2283
20. Mayosi B.M., Avery P.J., Baker M., et al. Genotype at the -174G/C polymorphism of the interleukin-6 gene is associated with common carotid artery intimal-medial thickness: family study and meta-analysis. Stroke 36 (2005) 2215-2219
21. Tso A.R., Merino J.G., and Warach S. Interleukin-6 174G/C polymorphism and ischemic stroke: a systematic review. Stroke 38 (2007) 3070-3075
22. Basso F., Lowe G.D., Rumley A., McMahon A.D., and Humphries S.E. Interleukin-6 -174 G>C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS). Arterioscler Thromb Vasc Biol 22 (2002) 599-604
23. Aromaa A., and Koskinen S. Health and functional capacity in Finland. Baseline results of the Health 2000 health examination survey. Publications of the National Public Health Institute B12/2004 (2004), National Public Health Institute, Helsinki
24. Niiranen T.J., Jula A.M., Kantola I.M., Karanko H., and Reunanen A. Home-measured blood pressure is more strongly associated with electrocardiographic left ventricular hypertrophy than is clinic blood pressure: the Finn-HOME study. J Hum Hypertens 21 (2007) 788-794
25. Sipilä K., Moilanen L., Nieminen T., et al. Metabolic syndrome and carotid intima media thickness in the Health 2000 Survey. Atherosclerosis 204 (2009) 276-281
26. Livak K.J. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 14 (1999) 143-149
27. Excoffier L., Laval G., and Schneider S. Arlequin ver. 3.0: an integrated software package for population genetics data analysis. Evol Bioinform Online 1 (2005) 47-50
28. Balding J., Livingstone W.J., Pittock S.J., et al. The IL-6 G-174 C polymorphism may be associated with ischaemic stroke in patients without a history of hypertension. Ir J Med Sci 173 (2004) 200-203
29. Boiardi L., Casali B., Farnetti E., et al. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica. J Rheumatol 33 (2006) 703-708
30. Mysliwska J., Wieckiewicz J., Hak L., et al. Interleukin 6 polymorphism corresponds to the number of severely stenosed coronary arteries. Eur Cytokine Netw 17 (2006) 181-188
31. Fernandez-Real J.M., Broch M., Vendrell J., Richart C., and Ricart W. Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J Clin Endocrinol Metab 85 (2000) 1334-1339
32. Henningsson S., Hakansson A., Westberg L., et al. Interleukin-6 gene polymorphism -174G/C influences plasma lipid levels in women. Obesity (Silver Spring) 14 (2006) 1868-1873
33. Goyenechea E., Parra D., and Martinez J.A. Impact of interleukin 6 -174G>C polymorphism on obesity-related metabolic disorders in people with excess in body weight. Metabolism 56 (2007) 1643-1648
34. Fried S.K., Bunkin D.A., and Greenberg A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83 (1998) 847-850
35. Pottratz S.T., Bellido T., Mocharla H., Crabb D., and Manolagas S.C. 17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest 93 (1994) 944-950
36. Mohamed-Ali V., Goodrick S., Rawesh A., et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82 (1997) 4196-4200
37. Yudkin J.S., Yajnik C.S., Mohamed-Ali V., and Bulmer K. High levels of circulating proinflammatory cytokines and leptin in urban, but not rural, Indians. A potential explanation for increased risk of diabetes and coronary heart disease. Diabetes Care 22 (1999) 363-364
38. Terry C.F., Loukaci V., and Green F.R. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 275 (2000) 18138-18144
39. Heinrich P.C., Castell J.V., and Andus T. Interleukin-6 and the acute phase response. Biochem J 265 (1990) 621-636
40. Keller E.T., Wanagat J., and Ershler W.B. Molecular and cellular biology of interleukin-6 and its receptor. Front Biosci 1 (1996) d340-d357